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Directed By: Dr. Volker Briken, Department of Cell Biology 
and Molecular Genetics 
 
The nuoG gene of Mycobacterium tuberculosis (Mtb) has the ability to inhibit host 
cell apoptosis. This ability is a virulence factor and does not exist in facultative 
pathogenic and non-pathogenic mycobacterial species. NuoG is part of the NDH-1 
complex, and this study addressed the potential link between the role of NuoG in 
apoptosis inhibition and the biochemical activity of the NDH-1 complex. Different 
mycobacterial species were tested for their NDH-1 activities. Among the bacteria 
tested were bacteria transformed with the Mtb nuoG plasmid, or with the almost 
entire NDH-1 coding region. Surprisingly, the levels of NDH-1 activity did not 
correlate with apoptosis levels, suggesting a potential independent, novel mechanism 
by which NuoG inhibits host cell apoptosis.  
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Enzymatic activity of NDH-1 is related to anti-apoptotic capacity of the NuoG 
subunit of NDH-1 and to virulence in mycobacteria. 
  
Aims 
1) Correlate NDH-1 enzymatic activity of various mycobacterial species with 
pathogenicity. This aim can support the hypothesis that high NDH-1 activity is 
related to a high degree of virulence in mycobacteria. 
2) Correlate NuoG proteins from different mycobacteria with NDH-1 enzymatic 
activity. This will be done by analyzing enzymatic activity in bacteria containing 
the TB nuoG plasmid, and the cosmid containing almost the entire TB nuo operon 
(“gain of function”). This aim can demonstrate whether NuoG of the virulent Mtb 
will result in higher NDH-1 activity when transformed into less virulent 
mycobacterial species. 
3) Create molecular tools for future NDH-1 activity studies of the different 
mycobacterial nuoG proteins. This will be done by creating nuoG plasmids (myc-
tagged and untagged) of different mycobacteria to be used in NDH activity studies 
and apoptosis assays. These plasmids can be transformed into BCGΔnuoG and 
TBΔnuoG bacteria in order to compare the impact of the different mycobacterial 
nuoG proteins on NDH-1 enzymatic activity. Creating an antibody against NuoG 
will serve as a tool to study the localization of NuoG and therefore verify that NuoG 




Chapter 1: Introduction 
 
Mycobacterium tuberculosis 
The global importance of tuberculosis (TB) is enormous and constantly 
growing. Currently, about one third of people are infected with TB, and it is 
estimated that 2.5 million people die of TB annually (Dye 2005). The HIV epidemic 
provides large numbers of easy human targets, as HIV positive individuals are 
extremely prawn to reactivation of latent TB infections (Barnes 1994). Multi-drug 
resistant (MDR) strains of Mtb have surfaced in 70 countries, with 400,000 new 
cases occurring each year (Jacobs 2003, Matteelli 2007). Extreme-drug resistant 
(XDR) strains have been increasingly emerging worldwide. An XDR TB outbreak 
that occurred in South Africa in 2007 resulted in 52 deaths out of 53 cases within 16 
days (Singh 2007).  
The chemotherapy of Mtb includes a combination of strong antibiotics taken 
daily for a period of 6-9 months. In addition to potential side effects such as liver 
damage, the drugs efficacy is decreasing as the number of MDR and XDR cases are 
increasing. The live vaccine strain used against TB is Bacillus Calmette-Guerin 
(BCG) and was derived from a virulent bovine strain called M. bovis. This vaccine 
has been used for the past 87 years, and although it is safe it is highly inefficient 







Mtb initially infects the alveolar macrophages in the lungs, and can be 
spread via aerosolized droplets to uninfected individuals (Jacobs 2003). The 
bacteria multiply within the macrophage and then disseminate throughout the body. 
Once the adaptive immune response is activated, the bacterial burden is controlled 
in 90% of infected individuals. These individuals are considered to have a latent 
infection, with a low number of TB bacilli persisting in their lungs.  
 
Mycobacteria and apoptosis 
Although macrophages have the ability to destroy the majority of invaders, 
Mtb is able to persist and to replicate within the host macrophage. Mtb has the 
ability to manipulate its host cells on many levels. One example is the role of the 
mycobacterial cell-wall lipids and mycobacterial protein kinase G in inhibition of 
phagosome maturation (Walburger 2004, Pethe 2004). The research in my lab 
addresses the ability of Mtb to influence host cell apoptosis.    
The induction of apoptosis following infection by a pathogen is highly 
conserved among the animals and plant kingdoms (Abramovitch 2004, Iriti 2007). 
Since apoptosis plays an important role in the innate immune response against 
pathogens, it is essential for a pathogen to combat apoptosis in order to persist. One 
study showed that apoptotic cell death reduced the viability of the mycobacteria, 
whereas necrotic cell death did not (Pan 2005). Apoptosis also plays a big role in 
initiating an adaptive immune response against Mtb. Phagocytosis of Mtb apoptotic 
bodies by dendritic cells (DCs) causes presentation of peptide antigens, leading to 
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specific T cell activation (Schaible 2003). In addition, cross priming occurs as 
extra-cellular antigens are presented on MHC I molecules and activate cytolytic T 
cells (Guermonprez 2005).  
There are contradictory reports about the outcome of Mtb in regards to 
apoptosis. Several reports show that virulent Mtb induces apoptosis in host cells, 
while others show inhibition of apoptosis by Mtb. These differences can be 
reconciled by understanding the complexity of the experimental system that 
depends on many variables. For example, primary alveolar macrophages obtained 
from Mtb infected individuals showed a higher level of macrophage apoptosis when 
compared to macrophages from healthy individuals (Klingler 1997, Placido 1997). 
However, there is increasing evidence that virulent Mtb inhibits host cell apoptosis. 
One study showed that virulent species of Mycobacteria, such as Mtb Erdman and 
M.bovis, induced much lower levels of apoptosis in primary human alveolar 
macrophages than non-virulent mycobacterial species, such as BCG and 
M.smegmatis (Keane 2000).   
 
Mycobacterial proteins involved in apoptosis inhibition 
The Mtb protein SecA2 is implicated in the inhibition of apoptosis. SecA2 
codes for a secretion system that mediates secretion of superoxide dismutase A 
(SodA), an enzyme that catalyzes the conversion of superoxide ions to hydrogen 
peroxide. SecA2 deletion mutants induced more apoptosis than wild-type Mtb 
(Braunstein 2003).  A second protein involved in host apoptosis inhibition is protein 
kinase E (PknE). PknE is a serine threonine kinase whose promotor is induced 
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during nitric oxide (NO) stress. PknE deletion mutants were more susceptible to 
NO, and also exhibited higher levels of apoptosis (Jayakumar 2007).  A third 
protein, nuoG, inhibits host cell apoptosis and is the subject of my research. 
 
Gain-of –function genetic screen for anti-apoptotic genes in Mtb: 
To identify the genes in Mtb that are behind the anti-apoptotic phenotype, a 
gain-of-function genetic screen was established using the non-pathogenic 
M.smegmatis mc2 155 strain (Msmeg). This strain is fast growing and highly 
transformable. The host cell used was the human cell line THP-1, which in 
publications was shown to be an accurate model for the apoptotic response of Mtb-
infected primary human alveolar macrophages (Reindeau 2003).  The gain-of-
function was performed using a library of 312 M.smeg clones containing Mtb 
genomic DNA fragment on an episomal cosmid. The two clones, “J21” and “M24”, 
which contained non-overlapping Mtb genomic DNA inserts, showed the most 
significant reduction in apoptosis (appendix 1). 
The two cosmids were then transformed into M. kansasii (Mkans), an 
opportunistic pathogen and strong (yet slow) inducer of apoptosis. Based on 
fluorescence activated cell sorter (FACS) analysis and terminal deoxynucleotidyl 
transferase dUTP nick end labeling (TUNEL) staining, wild type Mkans and Mkans 
with the empty cosmid vector (CO) induced high levels of apoptosis at 5 days post 
infection (95% and 86%, respectively). Mkan-J21 and Mkan-M24 showed 
significantly reduced levels of apoptosis (16% and 19%, respectively) (Figure 1). 
The transfection of the two cosmids into M.Kansasii and M.Smegmatis did not 
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affect in vitro growth.  In vivo, Mkan-J21 and Mkan-M24 showed significantly 
increased virulence in SCID mice (44 d and 60 d respectively, verses >200 d for the 
Mkan-CO) (Figure 2). 
The Mkans-J21 was chosen for further studies, as it induced higher 
virulence in SCID mice than the Mkan-M24. The Mkan-J21 cosmid contained 
almost the entire nuo operon (with half of nuoA missing), which encodes for the 14 
subunit Mtb type I NADH dehydrogenase complex (NDH-1), along with other 
known-function and predicted-function genes. To identify which genes conferred 
the anti-apoptotic phenotype, a series of deletion mutants was created in Mtb 
H37Rv (virulent strain) using specialized transduction (Bardarov 2002). While 
several deletion mutants showed modest effect on virulence in SCID mice and loss 
of apoptosis with THP-1 cells, the mutant with the deletion of the nuoG gene 
showed significant differences. The region of the cosmid named “7/10” also 
induced apoptosis when deleted (unpublished), but to a lesser degree than nuoG.  
Using reverse transcriptase-PCR the transcription of nuoG from the J21 cosmid in 
M.smegmatis was confirmed. A complementation was performed using the plasmid 
carrying nuoG behind a constitutively active promotor that integrates into the Mtb 
chromosome at a unique attB site (Stover 1991). The complementation verified that 
there are no polar effects of the deletion on nearby genes, and gave full 
complementation for the in vitro assays (Figure 1 C). 
The difference in apoptosis induction was proven to not be a result of 
reduced phagocytosis of the nuoG mutant. This was shown by comparing rates of 
infection via acid-fast staining and CFU determination. The MtbΔnuoG  mutant still 
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induced less apoptosis than M.Kansasii  in THP-1 cells and cultured primary mouse 

























  nuoG is an anti-apoptosis gene of Mtb  
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Figure 1. nuoG is an anti-apoptosis gene of Mtb. Induction of apoptosis by infection of differentiated 
human THP-1 cells with wild type (Mtb), the nuoG deletion mutant (MtbΔnuoG), or complemented 
mutant (MtbΔC). Cells were harvested at day 3 after infection, stained by tunnel assay and analyzed 
using flow cytometry (A). The J21 and M24 cosmids and empty vector cosmid (CO) were 
transfected into M.kansasii, and the induction of apoptosis was compared to uninfected and Mtb-
infected THP-1 cells using TUNEL at day 5 post-infection (B). M.smegmatis was transfected with 
the J21 and M24 cosmids, as well as with the purified and re-transfected J21-b and M24-b clones. 
The clones, original transformants, uninfected cells (UI), M.smegmatis (Msm) and BCG were tested 
for apoptosis induction following infection of THP-1 cells, TUNEL staining 16 h post-infection, and 
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Figure 2. Survival of immunocompetent BALB/c mice after intravenous infection with 106 wild type 
Mtb (squares), MtbΔnuoG (filled triangles), or complemented MtbΔnuoG (empty triangles). n=7 
mice per group (A). Survival of SCID mice infected with the bacterial strains as in A. n=7 mice per 




The mycobacterial nuoG  
The first anti-apoptotic gene that was identified by our lab, nuoG, is a part 
of the nuo operon and codes for a protein NDH-1. NDH-1 is a proton-pumping 
NADH ubiquinone reductase, and is also called respiratory complex 1. It is the first 
enzyme of the bacterial and mitochondrial respiratory chain. It catalyzes the transfer 
of two electrons from NADH to quinone, coupled with the translocation of four 
protons across the membrane (Sazanov 2006, Walker 1992). The mitochondrial 
complex contains 46 proteins, whereas the bacterial complex contains 14 (Matsuno-
Yagi 2003). The structure of the NDH-1 of mycobacteria hasn’t been studied. 
However, extensive research has been conducted on the analogous E.coli NDH-1. 
Electron microscopy showed that both the bacterial and mitochondrial enzyme have 
an L shaped structure (Sazanov 2003) (Figure 3 A and B). The peripheral 
hydrophilic domain contains flavin-mononucleotide (FMN), the NADH-binding 
site, and eight or nine iron-sulfur (Fe-S) clusters. The membrane embedded domain 
contains the proton-pumping machinery. FMN accepts two electrons 
simultaneously (as a hydride) from NADH and transfers them one by one to the 
electron carriers, the Fe-S clusters. These reduce the membrane-embedded quinone 
to quinol in two one-electron steps (Matsuno-Yagi 1997, Finel 2001). 
Mtb has two additional non-proton pumping type II NADH dehydrogenases 
encoded by the ndh and the ndhA genes. This supports the evidence that NDH-1 is 
not essential for mycobacterial growth in culture. Sequence comparisons revealed 
that nuoG of Mtb is 99.9% homologous to that of BCG, 70% identical to that of 
M.smegmatis, and 58% identical to that of M.kansasii.  
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To determine whether nuoG is secreted and effects cell signaling directly, a phoA-
nuoG fusion protein was created. This protein, if secreted, can convert a colorless 
substrate to blue. The assay did not show that nuoG is secreted (Miller et. al 
unpublished, Figure 3 C). Supporting this conclusion is the fact that NuoG lacks a 
signal peptide and has a predicted cytosolic location. If the structure of the 
mycobacterial Ndh-1 is similar to that of other bacterial Ndh-1 complexes (such as 





















                      NuoG is part of the NDH-1 complex and is not secreted 
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Figure 3. Cartoon representation of the NDH-1 complex. NuoG is in yellow (A). Diagram of the 
NDH-1 complex with the sub-units labeled for function/ predicted function (B). The nuoG-phoA 
fusion protein expressed in M .smegmatis. If the protein is secreted it turns the colorless substrate 

























The mechanism of apoptosis inhibition by Mtb 
Mtb can inhibit apoptosis via both the intrinsic and the extrinsic pathways.  
A study showed that inhibition of the intrinsic/ mitochondria-mediated pathway can 
involve the BCL-2 like genes mcl-1 and A1 (Spratt 2005). Another study showed 
that caspases 8 and 10, which are involved in the extrinsic/ death receptor-mediated 
pathway, were activated following Mtb infection (Braunstein 2000). Therefore, Mtb 
probably inhibits apoptosis via multiple pathways.  
NuoG inhibits apoptosis via the extrinsic pathway. Experiments performed 
in our lab by Jessica Miller showed that nuoG inhibition of apoptosis is dependant 
on caspase 8 (extrinsic pathway) but not caspase 9 (intrinsic pathway). Additional 
experiments performed by Miller showed that TNF-α mediated the MtbΔnuoG 
induction of apoptosis, TNF-α secretion was ROS dependant, and ROS were 
generated by the bacterial NADPH oxidase complex (NOX2).  One study done by 
Miller showed that in macrophages with a deletion of the gp91 that results in an 
inactive NOX2 complex, deleting nuoG does not abolish apoptosis inhibition 
(Miller et. Al unpublished, Figure 4). 
 
Reactive Oxygen Species (ROS) and apoptosis 
The mechanism of apoptosis inhibition by nuoG involves targeting the 
reactive oxygen species (ROS) created by the host cell phagocyte NADPH oxidase 
(NOX2) (Briken 2007).  NOX2 is a multi subunit complex that become recruited 
and activated onto the phagosomal membrane upon phagocytosis of pathogens 
(Purdy 2005, Behr 1999). It oxidizes NADPH in the cytosol to NADP+, and 
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reduces oxygen in the lumen to superoxide. The superoxide, which is very reactive 
and bactericidal, will generate further ROS. An increase in ROS in the lumen might 
cause an increase in ROS to the cytosol and cause change in TNF-alpha signaling 
from survival to cell death. The increase in cytosolic ROS can trigger inactivation 
of the MAP Kinase Phosphatase (MKP), resulting in sustained Jun N-terminal 


































Figure 4. Macrophages derived from C57B1/6 and gp91-KO mice were infected with Mtb and 
MtbΔnuoG. The gp91 mice have an inactive NOX2 complex. The cells were infected for 4 h, chased 











The model for the nuoG-mediated inhibition of host cell apoptosis proposed 
by our lab is as follows. Upon phagocytosis of bacteria, NOX2 gets recruited to the 
phagosomal membrane and activated. The NOX2 generate a lot of ROS, which are 
extremely bactericidal. The NDH-1 complex neutralizes the ROS by pumping 
protons into the phagosomal lumen, which then quickly react with the superoxide . 
The reaction is catalyzed by the bacterial superoxide dismutase enzyme (SOD). The 
reaction generates hydrogen peroxide, which is then transformed into water and 
oxygen by another reaction, catalyzed by the bacterial catalase enzyme. We 
hypothesize that deleting nuoG creates a non-functional NDH-1. If the NDH-1 does 
not neutralize the superoxide it reacts with other substrates to generate ROS. The 
ROS will accumulate until it will leak into the cytosol of the host cell. High levels 
of cytosolic ROS can activate JNK and also induces an increase in TNF-α. The 
increase in TNF-α creates a positive feed-back loop, with the secreted TNF-α 
binding to its receptor and leading to more JNK activation. Activated JNK leads to 












                                           Working model 
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Figure 5. In the wild type bacteria, NDH-1 (containing NuoG) pumps protons into the phagosomal 
lumen. The protons react with the superoxide in a reaction catalyzed by the bacterial superoxide 
dismutase (SOD). Hydrogen peroxide is generated, which is then transformed into water and oxygen 
in a reaction catalyzed by the bacterial catalase (Miller et al unpublished) (A). In the nuoG deletion 
mutant NOX2 (Phox) gets recruited and activated upon phagocytosis of bacteria. This increases the 
amount of superoxide in the phagosome, leading to the generation of bactericidal ROS. The ROS 
leaks into the cytosol of the macrophage, activates JNK and leads to a pro-apoptotis signaling 






Chapter 2: Results 
 
Membrane isolations 
In order to study the NDH-1 activities of the different mycobacterial species, 
membranes were isolated from one, two, or three separate preps of BCG, Mkans, 
Msmeg, Msmeg+ J21, and Msmeg+ pmv261-nuoG. Membrane isolations were 
performed via ultra-centrifugation, following the breaking of the bacteria with a 
French-press (see material and methods). 
 
Establishing the NDH activity assays 
Different titrations of membrane preps and Nhdh/ Nadh substrates were tested to 
establish the optimal conditions for the experiment. The titrations revealed that 20 
µl of 0.8 µg/ml membrane preps achieved comparable results to double and triple 
the amounts of membrane preps. Since the final amount of membrane preps 
produced from 500 ml bacterial cultures were small, 20 µl of membranes were 
established as the standard for all experiments (Figure 6).  Using 20 µl of 20 µM 
Nhdh/Nadh achieved significant NDH-1/ NDH-2 activity. Doubling and tippling 
the amounts of nhdh/nadh achieved higher activity readings, however the 
correlation was not linear. Since the Nhdh is extremely expensive, using 20 µl of 










Figure 6. 20, 40, and 60 µl of 20 mM Nhdh were used to calculate NDH-1 enzymatic activity in 















Figure 7. 20, 40, and 60 µl of 0.8 µg/ml membrane preps were used to calculate NDH-1 enzymatic 












Performing NDH-1 and NDH-2 activity assays 
In order to compare the NDH-1 and NDH-2 activities of the different 
mycobacteria, 
NDH-1 and NDH-2 assays were performed (see material and methods for a detailed 
protocol).NADH reduction occurs according to the following formula. 
NADH + Q  + 5H+n ⇒ NAD+  + QH2 + 4H+p 
Q- quinone. H+n-, H+p – the protons taken from the negative inner side to the 
positive outer side.  
NADH is a substrate specific for NDH-2 activity, and NHDH is a substrate 
specific for NDH-1 activity (Appendix 2). The two substrates are structurally 
similar, the only difference being that NHDH has a carbonyl where NADH has an 
amine. DCIP was used as a substrate in place of quinone, and reduction of DCIP 
was measured by plotting OD over time as the blue substrate turned colorless. 
Assays were performed in triplicates for all of the above mentioned membrane 
preps. Kinetic slopes were obtained and used to calculate the enzymatic 
biochemical activities.  
A previous experiment performed by collaborator Catherine Vilcheze from 
the Albert Einstein school of Medicine, revealed that deleting nuoG abolished the 
NDH-1 activity of BCG, but not the NDH-2 activity (Figure 8). My experiments 
were designed to measure NDH-1 activities and correlate them with the endogenous 
NuoG proteins of the different bacteria, as well as test for “gain of function” 
following transformation with a Mtb nuoG plasmid or a cosmid containing Mtb 
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nuoG. The raw data is presented in the form of the NDH-1 kinetic slopes (Figures 9 
and 11). 
 Potassium cyanide was used to inhibit the reaction, and had an activity 
value close to zero. As a negative control, the experiment was performed using 
water instead of membrane preps, and the resulting activity was three-fold lower 
than activities of BCG and Mkans NDH-1 enzymes (Figure 10). The NDH-1 
activities of BCG and Mkans were not significantly different, indicating that the 
low-apoptosis inducing BCG has similar NDH-1 activity to the high-apoptosis 
inducing Mkans. In NDH-1 experiments performed in Msmeg, Msmeg+nuoG, and 
Msmeg+ J21, the enzymatic activities proved to be similar (Figure 12). This result 
indicates that no enzymatic “gain of function” was observed when adding the nuoG 
or the nuo operon of low-apoptosis inducing Mtb to high-apoptosis inducing 
Msmeg. The NDH-1 activities of all the Msmeg bacteria were low- approximately 
50% higher than the activity of the negative control (water).  
When comparing the NDH-1 of the facultative pathogenic BCG and Mkans, 
to the non pathogenic Msmeg bacteria (with and without plasmids/ cosmids), it 
appears that the activity of the facultative pathogenic BGC and Mkans is two fold 
higher than that of the non pathogenic Msmeg bacteria, and three-fold higher than 
the negative control activity (Figure 13).  
Levels of NDH-2 activity of the different mycobacteria were measured as a 
control. NDH-2 in a non-proton pumping NADH deydrogenase that has no 
correlation with host cell apoptosis and was therefore expected to have similar 
activities in the different mycobacteria. The kinetic slopes were found to be similar 
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in all the mycobacteria tested (Figures 14 and 15). The NDH-2 activities of the 



































Figure 8. Membrane fractions of BCG, BCGΔnuoG, and complemented BCG (BCGΔc) were 










































            NDH-1 assays for BCG, Mkans, neg. control, and inhibitor 






Figure 9. Kinetic slopes for NDH-1 assays are shown as reduction of OD over time. Kinetic slopes 
were measured following the addition of the DCIP substrate to BCG, Mkans, phosphate buffer (neg. 
control), or phosphate buffer with 20 mM KCN (inhibitor of the reaction). Different colored lines 








           
 
 
Figure 10. NDH-1 activity was calculated for BCG, Mkans, neg. control, and the inhibitor (KCN). 
The activity was calculated by dividing the kinetic slopes shown in figure with the multiplicity of the 














                        NDH-1 assays of Msmeg, Msmeg+nuoG, Msmeg+J21 
 
                                
                                 
                              
 
Figure 11. Kinetic slopes for NDH-1 assays are shown as reduction of OD over time. Kinetic slopes 
were measured following the addition of the DCIP substrate to Msmeg, Msmeg+nuoG, and 
Msmeg+J21. Different colored lines indicate separate reactions and different numbers indicate 








    





Figure 12. NDH-1 activity was calculated for Msmeg, Msmeg+nouG, Msmeg+J21, neg. control, and 
the inhibitor (KCN). The activity was calculated by dividing the kinetic slopes shown in figure with 



















Figure 13. NDH-1 activity was calculated for Msmeg, Msmeg+nouG, Msmeg+J21, BCG, Mkan, 
neg. control, and the inhibitor (KCN). The activity was calculated by dividing the kinetic slopes 











 NDH-2 activity for Mkans, BCG, and neg. control 
 
                 
                
          
                           
                          
 
Figure 14. Kinetic slopes for NDH-2 assays are shown as reduction of OD over time. Kinetic slopes 
were measured following the addition of the DCIP substrate to BCG, Mkans, and neg. control. 
Different colored lines indicate separate reactions and different numbers indicate separate membrane 






        NDH-2 activities of Msmeg, Msmeg+nuoG, Msmeg+J21 
                      
                      
  
                      
 
 
Figure 15. Kinetic slopes for NDH-2 assays are shown as reduction of OD over time. Kinetic slopes 
were measured following the addition of the DCIP substrate to Msmeg, Msmeg+nuoG, and 
Msmeg+J21. Different colored lines indicate separate reactions and different numbers indicate 




         




Figure 16. NDH-2 activity was calculated for Msmeg, Msmeg+nouG, Msmeg+J21, BCG, Mkans, 
neg. control, and the inhibitor (KCN). The activity was calculated by dividing the kinetic slopes 











Creation of Myc-tagged and un-tagged NuoG plasmids 
In order to conduct future studies regarding the correlation of NuoG from 
different mycobacteria and NDH-1 enzymatic activity, Myc-tagged NuoG and 
untagged NuoG pmv261 plasmids were created with nuoG from Mtb, BCG and 
Msmeg (Figure 17). The protein products of the myc-tagged plasmids were verified 
in a western-blot using anti-myc antibodies. Topo vector nuoG plasmids of all the 
above myc-tagged and untagged nuoG genes were created, in addition to the Mkans 
untagged nuoG plasmid (material and methods). 
 
Creation of BCG∆nuoG bacteria transformed with Myc-tagged NuoG 
plasmids  
The plasmids mentioned above were used for transformation into competent 
BCG∆nuoG, to study potential “gain of function” phenotypes. Glycerol stock were 
made and stored at -80°C for future apoptosis and NDH-1 activity assays. 
 
Creation of Mtb∆nuoG bacteria transformed with Myc-tagged NuoG plasmids 
Mtb nuoG-myc plasmids from two separate preps (#2, #3) were 
electroporated into MtbΔnuoG bacteria that were made competent. Western blot 
revealed that the proteins extracted from the bacteria expressed the Mtb NuoG-Myc 
proteins (Figure 19). Glycerol stock were made and stored at -80°C for future 




Creation of plasmids for full-length and partial Mtb NuoG antibody 
production 
In order to study the potential role of nuoG in apoptosis inhibition, separate 
from it’s role as an NDH-1 subunit, an antibody against NuoG is needed for 
localization studies. The cloning of the plasmids for the Mtb NuoG-full length and 
the Mtb NuoG-short proteins were completed (material and methods). The short 
Mtb NuoG antibody will be used against different mycobacterial NuoG proteins, as 
the first 250 amino acids are conserved among mycobacterial species. The cloning 
























Figure 17. The Mtb nuoG was directionally cloned into the multiple cloning site of the pet28C 
vector. The region of the first 250 amino acids of the Mtb nuoG was similarly cloned into the pet28C 















Figure 18. The nuoG genes of Mtb, BCG and Msmeg were cloned into the non-integrating pmv261 
vector, both with myc tags and without them. The vector has a groEL promotor, a mycobacterial 









                          Mtb NuoG-Myc proteins are expressed in MtbΔnuoG 
                        
            
    
       
 






Figure 19. Mtb nuoG-myc plasmids from two separate preps (#2, #3) were electroporated into 
MtbΔnuoG bacteria that were made competent. The bacteria were grown on 7H10 agar plates with 
hygromycin (for selection of the MtbΔnuoG) and kenamycin (for selection of the pmv261 containing 
bacteria). Colonies were grown in 7H9 media with the antibiotics. Proteins were extracted and used 
for immunoblotting. 10, 20 and 30µl of the protein extractions were loaded on a gel alongside a 
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Chapter 3: Discussion 
            In my research, I have examined the correlation of enzymatic activity of 
NDH-1 and anti-apoptotic capacity/virulence of nuoG in mycobacteria. Currently, it 
is not possible to conclude with certainty the mechanism of apoptosis inhibition by 
nuoG. The working model of the Briken lab, which hypothesizes that it is the 
enzymatic activity of the NDH-1 complex that inhibits apoptosis, was not proven by 
this study. The idea that the facultative pathogenic Mkans and the non-pathogenic 
Msmeg didn’t have functioning NDH-1 complexes and therefore could not inhibit 
apoptosis like the pathogenic BCG and Mtb, was contradicted by the NDH-1 
activity assays. The level of NDH-1 activity of Mkans was comparable to that of 
BCG. The level of NDH-1 activity of Msmeg was only about 30% lower than that 
of BCG. Experiments using Mtb were not possible due to the fact that the French 
Press causes aerosolization of bacteria and cannot be used under Bio-Safety Level 3 
conditions. Since the NuoG protein sequences of BCG and Mtb are almost identical 
it is safe to conclude that the BCG results would be the same for Mtb.  
             Previous studies showed that transforming Msmeg with the J21 cosmid 
causes significant reduction in apoptosis. It would have been expected that the 
NDH-1 activity of the transformed Msmeg would be significantly higher than that 
of the wild type Msmeg, if in fact the enzymatic activity were related to apoptosis 
inhibition. However, the results didn’t show an increase, but a small, statistically 
insignificant decrease in activity. The J21 cosmid contains the 7/10 region which is 
involved in apoptosis inhibition, in addition to the nuo operon. The enzymatic 
activity assay implies that perhaps the 7/10 region is responsible for the anti-
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apoptotic phenotype in Msmeg transformed with J21. However, Mkans transformed 
with only the nuoG plasmid also showed apoptosis inhibition (Velmurugan 2007), 
indicating nuoG alone is sufficient for apoptosis inhibition in Mkans. In studies 
conducted in Msmeg, however, the wild type Msmeg, the Msmeg with the J21 
cosmid, and the Msmeg with the nuoG plasmid all had similar enzymatic activities.  
               The activity of the NDH-2 complexes was used as a control. All the 
bacteria that were compared for their NDH-1 activities showed similar NDH-2 
activities. The NDH-2 activities were significantly higher than the NDH-1 rates.  
This was expected since NDH-2 is only one protein and not a protein complex like 
NDH-1, and therefore a lot less fragile when subjected to the isolation procedure. 
Also, NDH-2 is non-proton pumping and its rate might therefore be higher than that 
of NDH-1. 
             The working model investigated in my lab suggests the novel function of 
apoptosis inhibition for the NDH-1 complex in addition to its function in 
respiration. It also suggests a novel function for the NOX2 complex. If the model is 
accurate, the NOX2 generated ROS serve as sensors in the macrophages for the 
presence of intracellular pathogens that remain alive. This is supported by the fact 
that more and more NOX2 evasion strategies are being revealed in intracellular 
pathogens.  
             However, if enzymatic activity is not related to anti-apoptotic capacity, the 
NuoG subunit of the complex could have an independent mechanism by which it 
inhibits apoptosis. If that is the case then nuoG directly effects cell signaling 
towards survival. It is possible it affects the extrinsic apoptosis pathway (caspase 8 
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mediated) by effecting TNFα secretion or TNFα binding to its receptor. It is also 
possible that it neutralizes ROS directly, by its ability to accept electrons. 
            To investigate whether the enzymatic activity is correlated to apoptosis 
inhibition, it would be interesting to investigate a different NDH-1 mutant. The 
Briken lab is in the final steps of generating a BCG nuoLM deletion mutant. The L 
and M subunits of the complex are the proton translocators, therefore deleting them 
should abolish the enzymatic activity on the NDH-1 complex. If the mutant shows 
very low levels of NDH-1 activity (like the BCG nuoG mutant showed), as well as 
induction of high levels of apoptosis, the enzymatic correlation to apoptosis will be 
supported. However, if the mutant shows very low levels of NDH-1 activity, but 
low rates of apoptosis similar to the low rates in wild type BCG, then the enzymatic 
correlation to apoptosis will be contradicted. Another experiment that would be 
helpful would be to test the levels of apoptosis in cells infected with Msmeg 
transformed with only the MtbnuoG plasmid. It would be interesting to see if 
apoptosis would be inhibited even though the enzymatic activity didn’t change. It 
would also be interesting to study the levels of enzymatic activity and apoptosis in 
Mkans transformed only with the Mtb nuoG plasmid. The Mkans with the Mtb 
nuoG plasmid are currently being grown in the lab and will be ready for use in the 
near future.  
          The nuoG plasmids created in this study should prove very useful for future 
“gain-of-function” studies. Wild type bacteria, but especially the Mtb and BCG 
nuoG deletion mutants can be transformed with the plasmids and tested for NDH-1 
activity and apoptosis inhibition, to search for correlation or lack of correlation. 
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The NuoG antibody, once produced, will be important for localization assays, 
especially if NuoG proves to function as an independent protein that effects host 
cell signaling. Finally, gold labeling followed by Electron microscopy would show 
if the NDH-1 complexes are located in proximity to the NOX2 complexes, and 
could support the correlation between the pumping of protons and subsequent 
neutralization of ROS, and inhibition of host cell apoptosis. 
            In conclusion, NuoG inhibits apoptosis in host cells either via its function as 
an NDH-1 subunit, or directly via effecting host cell signaling towards cell survival. 
Further studies are needed in order to support the current working model in the 
Briken lab, or to uncover a different mechanism for the inhibition of apoptosis by 
nuoG. In my project, I have established an assay and made the constructs required 
for investigating NDH-1 activities in different mycobacterial species. My results 
demonstrate previously unknown enzymatic activities of the different wild type 
bacteria and transformed bacteria. Using my data, the established assay and the 
constructs, it will be possible to complete the puzzle of whether NDH-1 enzymatic 










    Chapter 4: Experimental procedures 
 
     Bacterial and culture conditions 
         M. smegmatis (mc2155), M. kansasii (Hauduroy ATCC 12478) and Mtb 
(H37Rv ATCC 25618) were obtained from the American Type Culture 
Collection. M. bovis BCG Pasteur strain was obtained from the Trudeau Culture 
Collection (Saranac Lake, New York, United States).  The cultures were grown 
in Middlebrook 7H9 broth (Difco) supplemented with 0.5% glycerol, 10% oleic 
acid-albumin-dextrose-catalase (Difco), and 0.05% TWEEN-80, or on 
Middlebrook 7H10 agar (Difco). For selective media, 50 µl hygromycin or 40 
µl kanamycin were added. 
      
     Membrane isolations: 
               Mycobacterial cultures were grown in 7H9 media to OD(600nm)= 0.7-1.0 
in 2 L Roller Bottles. Cultures were spun down at 4,000 rpm for 15 minutes. 
The cultures were washed twice with 50mL cold phosphate buffer (50 mM 
KH2PO4 pH 7.5, 5 mM MgSO4). The pellet was weighed and recorded for later 
calculations. The pellet was re-suspended in 2 ml cold complete phosphate 
buffer containing DNase1(5,000 units, Roche), protease cocktail inhibitor 
solution (0.1 ml, Roche- dissolve in 1 ml TRIS-HCL) and soybean trypticase 
inhibitor (5 µl per 2 ml buffer). The cell suspensions were passed through a 
French Press (4 passages, 1000 psi/ cm2). The suspensions were spun to remove 
cell debris at 1,200 G for 20 minutes at 4 C°. 
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      The membrane fractions were isolated by ultracentrifugation at 100,000 G for 
90 minutes at 4 C°. The pellets were then re-suspend in 1 ml/gram pellet 
complete cold phosphate buffer. Protein concentrations were measured using 
the BCA assay kit.  
      
NADH assays: 
The rate of DCIP (2,6 dichlorophenolindophenol, 0.1 mM) reduction was 
measured at room temperature at 610 nm in the presence of NHDH (reduced 
nicotinamide hypoxanthine dinucleotide,0.4 mM) in phosphate buffer. 20 ul of 
membrane isolation preps were used per assay. The reduction was measured for 
200 seconds at 20 second intevrals. The kinetic slope was calculated using the 
spectrophotometer’s kinetic reaction function, and was indicated in centimeters 
per minute units. NADH activity was measured by dividing the kinetic slope by 
the multiplication of the DCIP extinction coefficient (16.5 mM-1cm-1) and the 
protein concentration. NDH-2 assays were performed similarly, replacing 
NHDH with NADH (reduced nicotinamide adenine dinucleotide). 
 
Creating the nuoG plasmids 
       The nuoG genes of were PCR amplified include the up-stream Shine- 
     Delgarno sequences and the downstream myc tag. The primers used were:  
     For Mkan- Forward primer: CGAATACGTCGCGCATGTCG. 
     Reverse primer: GAGTACGACTGGCAGGACCA. 
     For Mtb and BCG- Forward primer: CCTGGCCCACGTCGAAGGAG.  
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Reverse primer without adding myc tag: TGTCGGCGTACTGGGGGCAC. 
Reverse primer adding a myc tag: TCACAGGTCCTCCTCGCT 
      GATCAGCTTCTGCTCTAATGAGCCCGCTCCGATTT. 
      For Msmeg- forward primer: TGGCCGAACCGACCAAGGAC. 
      Reverse primer without adding myc tag: GAGCATGAGCCACCACGGATCG. 
      Reverse primer adding a myc tag: TCACAGGTCCTCCTCGCTGATCAGCTT 
      CTGCTCTAATGCCCCGGCTCCGATCG. 
       The stop codons were altered from TGA to TTA (leu). Blunt-end cloning 
was initially performed to clone the gene into the sequencing topo vector. The 
sequences   of the plasmids were verified. The genes were digested out of the topo 
vector using   the EcoRI enzyme at 37 C°, ran on a gel, then gel purification. The 
gene was  ligation into the mycobaterial non-integrating pmv261 vector. Restriction 
enzyme  digestion was performed to verify orientation of the insert.  
 
Plasmid sequencing: 
PCR amplification of the plasmids was performed with sequencing primers 
and Big Dye Terminator buffer and enzyme. The sequencing primers used were the 
commercial topo vector sequencing primers M13F and M13R. Following the PCR, 
40 µl of 75% isopropanol were added to each sample and gently vortexed. The 
samples were incubated at room temperature for 15 minutes. The samples were 
centrifuged for 30 minutes at 3770 revolutions per minute (RPM). The samples 
were decanted onto a paper towel and immediately spun at 2330 RPM for one 
minute.  75 µl of 70% isopropanol were added to each sample and gently vortexed. 
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The samples were centrifuged for 10 minutes at 3770 RPM. The samples were 
decanted onto a paper towel and immediately centrifuged at 2230 RPM for one 
minute. Samples were re-suspended in 10 µl HiDi formamide and vortexed. 
Samples were heated at 95 C° for two minutes then chilled on ice for five minutes. 
10 µl of each sample were loaded onto the sequencing plate, and loaded into the 
ABI 3100 sequencer. 
 
Introducing the nuoG plasmids into competent mycobacteria: 
50 ml of M.Smeg was grown to an O.D 600 of 0.5-1. The entire procedure is 
temperature sensitive and was performed in 4 °C (on ice). The culture was spun 
down   (3,000 rpm, 10 minutes), washed 3 times with 10% glycerol/ 0.05% Tween-
80. The pellet was taken up in 4 ml wash buffer, and was used immediately. 5 µl of 
the selected plasmids were placed in a biorac cuvette, with 400 µl of the competent 
smegmatis. The cells were electroporated at 2.5 kV, 25 µFD, 1000 om. The cells 
were immediately transferred to a round bottom PP tube containing 2 ml of medium 
without antibiotic. The culture was then incubated for 2 hours, shaking at 37 °C. 
Mtb nuoG-myc plasmids from two separate preps (#2, #3) were electroporated into 
MtbΔnuoG bacteria that were made competent. The bacteria were grown on 7H10 
agar plates with hygromycin (for selection of the MtbΔnuoG) and kenamycin (for 






Creating anti-NuoG antibody 
Antibody is being created against the region of NuoG similar among strains 
(first 250 amino-acids), as well as against the full length Mtb NuoG. Primers were 
designed without a start codon (which is present in the plasmid), and with 
restriction enzyme sites that will allow directional cloning into pet28c vector. Once 
the PCR from J21 is amplified according to this method, the fragment is ligated into 
pet28C and transformed in competent E. coli cells. The plasmid will then will be 
propagated in BL21-DE3 cells. Once the culture is IPTG induced, and plasmids 
containing the insert are selected, a larger culture is grown (10 ml).  
The protein is purified using glass-beads, and the total protein runs on a 
coomasie-blue gel. NuoG is cut out of the gel, and his-tagged NuoG (which is the 
mycobacterial protein, not the E. coli protein) is purified using a his-column. The 
his tag is cleaved using the thrombine site, and the protein can be sent out to make 
polyclonal antibodies against. These antibodies will be affinity purified for NuoG 
specificity. 
 
Mycobacterial protein extraction 
10 ml cultures were grown from colonies of Mtb containing the nuoG-myc 
plasmids to an OD600 of 0.7. The culture was centrifuged at 2,000 X g for 20 
minutes to pellet the bacteria. The pellet was washed once with 10 ml phosphate-
buffered saline (PBS). Following additional centrifugation, the supernatants were 
discarded and 10 ml of ice-cold PBS was added to the cell pellet. The pellets were 
vortexed until resuspended, then spun for 10 minutes at 2,000 X g. The supernatants 
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were discarded and the cell pellet was resuspended in 1.5 ml ice-cold PBS. Cell 
pellets were vortexed until resuspended. The cell suspensions were transferred to a 
2 ml screw-cap tube. Tubes were spun for 10 minutes in a microcentrifuge. The 
supernatants were discarded and the cell pellets were resuspended in 500 µl of 
extraction buffer. 100 µl glass beads were added to the cells (106 µm glass beads, 
Sigma). The cells with the beads were vortexed at top speed for five minutes. The 
supernatant was collected and transferred into a new tube, and 100 µl of 5 X SDS-
PAGE sample buffer was added to each tube, and mixed by vortexing. The samples 
were incubated at 100 for 10 minutes. The samples were then moved from the Bio 
safety level (BSL)-3 lab to the BSL-2 lab, and immunoblotting assays were then 
performed.  
 
Immunoblot analysis of mycobacterial proteins 
10% HEPES gels were loaded with 10, 20 and 30 µl of protein samples and 
5 µl of protein ladder. The gel ran at 100 volt for 40 minutes in Hepes buffer. The 
gel was transferred onto an activated PVDF membrane (pre-immersed in 100% 
methanol, washed in transfer buffer) for one hour at 12 volts. The membrane was 
briefly washed in 0.05% tween-PBS buffer. The membrane was blocked in 5% milk 
in PBS for 15 minutes at room temperature. The membrane was washed for 15 
minutes with 0.05% tween-PBS, three times. The membrane was incubated with the 
mouse anti-myc primary antibody (9E10, development studies hybridoma bank, 
developed at the University of Iowa) for one hour at room temperature. The 
membrane was washed for fifteen minutes with 0.05% tween-PBS, three times. The 
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membrane was incubated with the secondary goat-anti-mouse antibody for one hour 
at room temperature. The membrane was washed for five minutes with 0.05% 
tween-PBS, five times. The membrane was then incubated in a 1:1 dilution of 
Luminol peroxidase buffer. The membrane was exposed for one munite on a film 
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